(Q77308098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

U Rühl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Albrecht

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

K Dieckmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

H Lüders

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

H Marciniak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

D Schellenberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

L Wickmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W Dörffel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1209-1218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

[Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study]

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

The Challenge of Pediatric Hodgkin's Disease-Where is the Balance Between Cure and Long-Term Toxicity?: A report of the West German multicenter studies DAL-HD-78, DAL-HD-82 and DAL-HD-85

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

ABVD chemotherapy in the treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

The effects of radiation therapy on bone growth

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Radiation induced height impairment in pediatric Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Second cancers following pediatric Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Factors affecting late mortality from heart disease after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Bacterial infections in pediatric Hodgkin's disease.Relationship to radiotherapy, chemotherapy and splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

An evaluation of abdominal staging procedures performed in pediatric patients with advanced Hodgkin's disease: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

With modern imaging techniques, is staging laparotomy necessary in pediatric Hodgkin's disease? A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Paediatric Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Thyroid dysfunction after radiotherapy in children with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Treatment of Hodgkin's disease in children with or without radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Hodgkin's disease in children. A ten-year experience in South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Prognostic factors in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901798-9

7 January 2021

10.1016/S0360-3016(01)01798-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11728679%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference